Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation and Comparative Multi-Omics Benchmarking of Fluid-Derived Volatilomics Biomarkers for the Prevention and Early Detection of Schizophrenia

NCT07876089 is registered in ClinicalTrials.gov with University Hospital, Aachen as lead sponsor.

NCT NCT07876089
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07876089 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation and Comparative Multi-Omics Benchmarking of Fluid-Derived Volatilomics Biomarkers for the Prevention and Early Detection of Schizophrenia
Lead sponsor
University Hospital, Aachen
Phase
Observational
Overall status
Active, not recruiting
Start date
March 5, 2026
Completion date
June 30, 2029
Enrollment
3,692 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia / schizoaffective disorder